Portfolio company
Spectacell
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a label-free single-cell analysis platform for pharmaceutical and biotechnology organisations to measure the performance of immune therapies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
Sarcura
This company develops automated platforms for large-scale manufacturing of personalised cell therapies for the biopharmaceutical industry.
CTRL Therapeutics
This company develops cell therapies for solid tumours and microfluidic platforms to identify rare tumour-reactive lymphocytes for cancer patients.
LiquidCell Dx
This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.
PreComb
This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.
Captain T Cell
The company develops cell therapies for cancer patients to treat solid tumours.
Sampling Human
This company develops single-cell analysis platforms and biocytometry kits for diagnostic, healthcare, and research organisations to improve early disease detection and treatment monitoring.
GraphTX
The company develops a platform for precision drug discovery by mapping live patient immune cell behaviour to identify therapeutic targets for inflammatory diseases.
